Evommune: the plunge stalls, the Sell signal eases
Evommune bounces 1.9%, carving a double bottom while the decline stays open
Evommune: the plunge stalls, the Sell signal eases
Our view last week
A new sell signal fires on Evommune: the week just closed down 48.5%. The signal strength sits at its peak, 100 out of 100, describing a decline that has started making lower lows on a highly volatile stock. The setup quality indicator, at 72 out of 100, stays in tension, and the stock ranks 56th among the 137 US sell signals.
This week's summary
Evommune bounces 1.9% after last week's plunge, carving a clean double bottom in the 13 area with a 13% intermediate rebound. In this week's technical analysis the Sell signal loses strength, dropping from 100 to 54 out of 100 — an isolated drop, no new lows — while the setup quality indicator eases to 64 out of 100. Our model flags a fresh short here as high-risk.
IQS Phase
64
ordinary
Signal Strength
54
isolated weekly drop
Sizing
STANDARD
Ranking
#10 / 137
US stocks sell signals
Trade P&L %
-1.93%
from signal to today
restricted Platinum content